Seladelpar is a selective peroxisome proliferator-activated receptor delta (PPAR-δ) agonist designed to modulate bile acid metabolism and inflammation pathways, specifically indicated for the treatment… Read more























Seladelpar is a selective peroxisome proliferator-activated receptor delta (PPAR-δ) agonist designed to modulate bile acid metabolism and inflammation pathways, specifically indicated for the treatment of primary biliary cholangitis. Within the pharmaceutical research landscape, this category provides a comprehensive collection of high-quality reference materials essential for the rigorous analytical evaluation of the active pharmaceutical ingredient. Laboratories rely on these substances, including systemic impurities, metabolites, and degradation products, to facilitate accurate impurity profiling and to establish reliable methods for quality control. Furthermore, researchers utilize stable isotope-labelled compounds as critical internal standards to ensure precision during mass spectrometry-based assays. By offering a range of these related reference standards, the collection supports the development of robust analytical protocols, ensuring compliance with strict regulatory standards and maintaining the safety and efficacy of the final therapeutic product throughout its lifecycle.